1、The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for thecontents of this Application Proof,make no representation as to its accuracy or completeness and expressly disclaimany liability whatsoever for any loss howsoever arising from or in relian
2、ce upon the whole or any part of the contentsof this Application Proof.Application Proof ofDuality Biotherapeutics,Inc.映恩生物*(the“Company”)(Incorporated under the laws of the Cayman Islands with limited liability)WARNINGThe publication of this Application Proof is required by The Stock Exchange of Ho
3、ng Kong Limited(the“StockExchange”)and the Securities and Futures Commission(the“Commission”)solely for the purpose of providinginformation to the public in Hong Kong.This Application Proof is in draft form.The information contained in it is incomplete and is subject to change whichcan be material.B
4、y viewing this document,you acknowledge,accept and agree with the Company,its joint sponsors,overall coordinators,advisors or members of the underwriting syndicate that:(a)this document is only for the purpose of providing information about the Company to the public in Hong Kongand not for any other
5、 purposes.No investment decision should be based on the information contained in thisdocument;(b)the publication of this document or supplemental,revised or replacement pages on the Stock Exchangeswebsite does not give rise to any obligation of the Company,its joint sponsors,overall coordinators,adv
6、isorsor members of the underwriting syndicate to proceed with an offering in Hong Kong or any other jurisdiction.There is no assurance that the Company will proceed with the offering;(c)the contents of this document or any supplemental,revised or replacement pages may or may not be replicatedin full